Srovnání celkového přežití u pacientů po resekci a perkutánní ablaci pro tumor ledviny

Warning

This publication doesn't include Faculty of Education. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Title in English Comparison of overall survival in patients after resection and percutaneous ablation of renal tumor
Authors

VÁLEK Vlastimil ROHAN Tomáš ANDRAŠINA Tomáš FEDORKO Michal HUSTÝ Jakub FOUKAL Jakub MECHL Marek

Year of publication 2022
Type Article in Periodical
Magazine / Source Česká radiologie
MU Faculty or unit

Faculty of Medicine

Citation
Web http://www.cesradiol.cz/detail.php?stat=786
Keywords ablation; microwaves; readiofrequency ablation; renal cell carcinoma; resection
Description Aim: To compare overall survival in patients with renal tumor with signs of renal cell cardnoma according to CT after surgical procedure and percutaneous ablation. Methods: Our cohort included patients with tumor of renal cell cardnoma appearance on contrast enhanced CT treated with radical or partial nephrectomy or percutaneous ablation at the University Hospital Brno between 2010 and 2020. Overall survival, tumor size and localization, age, and gender were compared between patients with surgical resection and ablation. Among patients treated with ablation, the rate of complications after the procedure was analyzed in relation to tumor location and size, patient age, and the ablation method used. Results: The retrospective study included 109 consecutive patients (70% men) with 109 stage Tla tumor. The mean age of patients was 66.9 ? 11.9 years. Percutaneous ablation was used in 29 % (n = 32) of tumors, and surgical treatmentin 71 % (n = 77). The mean age of patients indicated for ablation was higher than in the group indicated for surgery (71.8 vs. 64.9 years, p = 0.004). There was no statistically significant difference between ablation and resection in overall survival, gender and tumor location. No significant factor assodated with complications of ablation procedures was found. Conclusion: Percutaneous ablation is an alternative method of treating renal cell carcinomas in patients who are not candidates for surgery. There was no significant difference in overall survival between patients after ablation and surgery.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.